{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:12:25Z","timestamp":1791663145066,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01908-4","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:54:44Z","timestamp":1762844084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The emerging role of cancer-associated fibroblasts in hematological malignancies: from their influence on tumor progression and drug resistance to novel therapeutic opportunities"],"prefix":"10.1007","volume":"25","author":[{"given":"Sahar","family":"Jalilivand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Yazdanparast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Bakhtiyaridovvombaygi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Izadirad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Mikanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Gharehbaghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"7","key":"1908_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers17071247","volume":"17","author":"B Bogdanovic","year":"2025","unstructured":"Bogdanovic B, Hugonnet F, Montemagno C. Theranostics in hematological malignancies: cutting-edge advances in diagnosis and targeted therapy. Cancers (Basel). 2025;17(7):1\u201324.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1908_CR2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12308-014-0214-3","volume":"7","author":"JA Ferry","year":"2014","unstructured":"Ferry JA. Thomas Hodgkin and Hodgkin lymphoma. J Hematop. 2014;7(3):123\u201338.","journal-title":"J Hematop"},{"key":"1908_CR3","first-page":"1","volume":"16","author":"S Liu","year":"2025","unstructured":"Liu S, Liu C, He Y, Li J. Benign non-immune cells in tumor microenvironment. Front Immunol. 2025;16:1\u201322.","journal-title":"Front Immunol"},{"issue":"16","key":"1908_CR4","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. Tumor microenvironment nicole. Curr Biol. 2020;30(16):R921.","journal-title":"Curr Biol"},{"key":"1908_CR5","first-page":"1","volume":"12","author":"PY Chen","year":"2021","unstructured":"Chen PY, Wei WF, Wu HZ, Fan LS, Wang W. Cancer-associated fibroblast heterogeneity: a factor that cannot be ignored in immune microenvironment remodeling. Front Immunol. 2021;12:1\u201311.","journal-title":"Front Immunol"},{"issue":"1","key":"1908_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12943-019-0994-2","volume":"18","author":"ME Fiori","year":"2019","unstructured":"Fiori ME, Di Franco S, Villanova L, Bianca P, Stassi G, De Maria R. Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance. Mol Cancer. 2019;18(1):70.","journal-title":"Mol Cancer"},{"issue":"3","key":"1908_CR7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-024-10186-7","volume":"43","author":"T Guo","year":"2024","unstructured":"Guo T, Xu J. Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy. Cancer Metastasis Rev. 2024;43(3):1095\u2013116.","journal-title":"Cancer Metastasis Rev"},{"key":"1908_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1596947","author":"C Pan","year":"2025","unstructured":"Pan C, Zheng L, Wang J. Cancer associated fibroblasts in tumors: focusing on solid tumors and hematological malignancies. Front Oncol. 2025;15:1596947.\u00a0https:\/\/doi.org\/10.3389\/fonc.2025.1596947.","journal-title":"Front Oncol"},{"issue":"1","key":"1908_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"IHM Elia","year":"2021","unstructured":"Elia IHM. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat Metab. 2021;3(1):21\u201332.","journal-title":"Nat Metab"},{"key":"1908_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093387","author":"SM El-daly","year":"2020","unstructured":"El-daly SM, Bayraktar R, Anfossi S, Calin GA. The interplay between micrornas and the components of the tumor microenvironment in B-cell malignancies. Int J Mol Sci. 2020;21(9):3387.\u00a0https:\/\/doi.org\/10.3390\/ijms21093387.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1908_CR11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao J, Zhang L, Wei F, Lian Y, Wu Y, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761\u201373.","journal-title":"J Cancer"},{"issue":"18","key":"1908_CR12","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557\u201366.","journal-title":"Cancer Res"},{"issue":"1","key":"1908_CR13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s40425-019-0667-0","volume":"7","author":"A Osipov","year":"2019","unstructured":"Osipov A, Saung MT, Zheng L, Murphy AG. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape. J Immunother Cancer. 2019;7(1):224.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"1908_CR14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, et al. Stromal cells in the tumor microenvironment\u202f: Accomplices of tumor progression\u202f? Cell Death Dis. 2023;14(9):587.","journal-title":"Cell Death Dis"},{"issue":"9","key":"1908_CR15","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41417-021-00318-4","volume":"28","author":"Q Ping","year":"2021","unstructured":"Ping Q, Yan R, Cheng X, Wang W, Zhong Y, Hou Z, et al. Cancer-associated fibroblasts: overview, progress, challenges, and directions. Cancer Gene Ther. 2021;28(9):984\u201399.","journal-title":"Cancer Gene Ther"},{"issue":"6","key":"1908_CR16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41568-018-0006-7","volume":"18","author":"S Maman","year":"2018","unstructured":"Maman S, Witz IP. A history of exploring cancer in context. Nat Rev Cancer. 2018;18(6):359\u201376.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1908_CR17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41392-021-00825-8","volume":"6","author":"W Li","year":"2021","unstructured":"Li W, Li F, Zhang X, Lin HK, Xu C. Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment. Signal Trans Targeted Ther. 2021;6(1):422.","journal-title":"Signal Trans Targeted Ther"},{"key":"1908_CR18","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/path.1398","volume":"200","author":"O De Wever","year":"2003","unstructured":"De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol. 2003;200:429\u201347.","journal-title":"J Pathol"},{"key":"1908_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JTO.0b013e3181f8a1bd","volume":"6","author":"RM Bremnes","year":"2011","unstructured":"Bremnes RM, D\u00f8nnem T, Al-Saad S, Al-Shibli K, Andersen S, Sirera R, et al. The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. J Thorac Oncol. 2011;6:209\u201317.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"1908_CR20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000089419","volume":"72","author":"T Akashi","year":"2005","unstructured":"Akashi T, Minami J, Ishige Y, Eishi Y. Basement membrane matrix modifies cytokine interactions between lung cancer cells and fibroblasts. Pathobiology. 2005;72(5):250\u20139.","journal-title":"Pathobiology"},{"issue":"6835","key":"1908_CR21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","volume":"411","author":"LA Liotta","year":"2001","unstructured":"Liotta LA, Kohn EC. The microenvironment of the tumour\u2013host interface. Nature. 2001;411(6835):375\u20139.","journal-title":"Nature"},{"issue":"1","key":"1908_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.1996.76.1.69","volume":"76","author":"L R\u00f8nnov-Jessen","year":"1996","unstructured":"R\u00f8nnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996;76(1):69\u2013125.","journal-title":"Physiol Rev"},{"issue":"5","key":"1908_CR23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4161\/cbt.6.5.4198","volume":"6","author":"A Giatromanolaki","year":"2007","unstructured":"Giatromanolaki A, Sivridis E, Koukourakis MI. The pathology of tumor stromatogenesis. Cancer Biol Ther. 2007;6(5):639\u201345.","journal-title":"Cancer Biol Ther"},{"issue":"9","key":"1908_CR24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1908_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392\u2013401.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"1908_CR26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/00387010.2016.1211708","volume":"49","author":"C G\u00f6tze","year":"2016","unstructured":"G\u00f6tze C, Gl\u00e4\u00dfer C. Spectral characterization of black materials for use as background in spectrometric laboratories. Spectrosc Lett. 2016;49(7):498\u2013505.","journal-title":"Spectrosc Lett"},{"issue":"2","key":"1908_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","volume":"18","author":"X Chen","year":"2019","unstructured":"Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18(2):99\u2013115.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1908_CR28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1908_CR29","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4161\/cc.8.10.8557","volume":"8","author":"C Anderberg","year":"2009","unstructured":"Anderberg C, Pietras K. On the origin of cancer-associated fibroblasts. Cell Cycle. 2009;8(10):1461\u20135.","journal-title":"Cell Cycle"},{"issue":"11","key":"1908_CR30","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3390\/cancers12113108","volume":"12","author":"K Louault","year":"2020","unstructured":"Louault K, Li RR, DeClerck YA. Cancer-associated fibroblasts: understanding their heterogeneity. Cancers. 2020;12(11):3108.","journal-title":"Cancers"},{"issue":"9","key":"1908_CR31","first-page":"863","volume":"5","author":"LT McDonald","year":"2012","unstructured":"McDonald LT, LaRue AC. Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin. Int J Clin Exp Pathol. 2012;5(9):863.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"1908_CR32","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1541-7786.MCR-17-0784","volume":"16","author":"CR Goulet","year":"2018","unstructured":"Goulet CR, Bernard G, Tremblay S, Chabaud S, Bolduc S, Pouliot F. Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFb signaling. Mol Cancer Res. 2018;16(7):1196\u2013204.","journal-title":"Mol Cancer Res"},{"issue":"18","key":"1908_CR33","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.7150\/thno.26546","volume":"8","author":"Q Sun","year":"2018","unstructured":"Sun Q, Zhang B, Hu Q, Qin Y, Xu W, Liu W, et al. The impact of cancer-associated fibroblasts on major hallmarks of pancreatic cancer. Theranostics. 2018;8(18):5072\u201387.","journal-title":"Theranostics"},{"key":"1908_CR34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.actbio.2018.07.001","volume":"76","author":"JH Yeon","year":"2018","unstructured":"Yeon JH, Jeong HE, Seo H, Cho S, Kim K, Na D, et al. Cancer-derived exosomes trigger endothelial to mesenchymal transition followed by the induction of cancer-associated fibroblasts. Acta Biomater. 2018;76:146\u201353.","journal-title":"Acta Biomater"},{"issue":"7","key":"1908_CR35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejcb.2018.07.005","volume":"97","author":"L Hong","year":"2018","unstructured":"Hong L, Du X, Li W, Mao Y, Sun L, Li X. EndMT: a promising and controversial field. Eur J Cell Biol. 2018;97(7):493\u2013500.","journal-title":"Eur J Cell Biol"},{"issue":"9","key":"1908_CR36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.bjc.6604662","volume":"99","author":"S Potenta","year":"2008","unstructured":"Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer. 2008;99(9):1375\u20139.","journal-title":"Br J Cancer"},{"issue":"12","key":"1908_CR37","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","volume":"5","author":"H Sugimoto","year":"2006","unstructured":"Sugimoto H, Mundel TM, Kieran MW, Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther. 2006;5(12):1640\u20136.","journal-title":"Cancer Biol Ther"},{"issue":"38","key":"1908_CR38","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1073\/pnas.1109493108","volume":"108","author":"JT O\u2019Connell","year":"2011","unstructured":"O\u2019Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, et al. VEGF-A and tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A. 2011;108(38):16002\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1908_CR39","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1038\/emm.2017.175","volume":"50","author":"J Jiao","year":"2018","unstructured":"Jiao J, Gonz\u00e1lez \u00c1, Stevenson HL, Gagea M, Sugimoto H, Kalluri R, et al. Depletion of S100A4(+) stromal cells does not prevent HCC development but reduces the stem cell-like phenotype of the tumors. Exp Mol Med. 2018;50(1):e422.","journal-title":"Exp Mol Med"},{"issue":"1","key":"1908_CR40","doi-asserted-by":"crossref","first-page":"15095","DOI":"10.1038\/ncomms15095","volume":"8","author":"JL Carstens","year":"2017","unstructured":"Carstens JL, Correa de Sampaio P, Yang D, Barua S, Wang H, Rao A, et al. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat Commun. 2017;8(1):15095.","journal-title":"Nat Commun"},{"issue":"5","key":"1908_CR41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.3818","volume":"49","author":"H Li","year":"2017","unstructured":"Li H, Courtois ET, Sengupta D, Tan Y, Chen KH, Goh JJL, et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet. 2017;49(5):708\u201318.","journal-title":"Nat Genet"},{"issue":"13","key":"1908_CR42","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/0008-5472.CAN-12-4150","volume":"73","author":"DE Costea","year":"2013","unstructured":"Costea DE, Hills A, Osman AH, Thurlow J, Kalna G, Huang X, et al. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. Cancer Res. 2013;73(13):3888\u2013901.","journal-title":"Cancer Res"},{"issue":"6","key":"1908_CR43","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/bjc.2014.438","volume":"111","author":"Y Hassona","year":"2014","unstructured":"Hassona Y, Cirillo N, Heesom K, Parkinson EK, Prime SS. Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion. Br J Cancer. 2014;111(6):1230\u20137.","journal-title":"Br J Cancer"},{"issue":"20","key":"1908_CR44","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/0008-5472.CAN-19-0454","volume":"79","author":"Y Mizutani","year":"2019","unstructured":"Mizutani Y, Kobayashi H, Iida T, Asai N, Masamune A, Hara A, et al. Meflin-positive cancer-associated fibroblasts inhibit pancreatic carcinogenesis. Cancer Res. 2019;79(20):5367\u201381.","journal-title":"Cancer Res"},{"issue":"4","key":"1908_CR45","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/cas.14346","volume":"111","author":"Y Miyai","year":"2020","unstructured":"Miyai Y, Esaki N, Takahashi M, Enomoto A. Cancer-associated fibroblasts that restrain cancer progression: hypotheses and perspectives. Cancer Sci. 2020;111(4):1047\u201357.","journal-title":"Cancer Sci"},{"issue":"3","key":"1908_CR46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"issue":"2","key":"1908_CR47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez CX, M\u00fcller S, Keerthivasan S, Koeppen H, Hung J, Gierke S, et al. Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy. Cancer Discov. 2020;10(2):232\u201353.","journal-title":"Cancer Discov"},{"issue":"4","key":"1908_CR48","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ajpath.2019.12.007","volume":"190","author":"X Zhao","year":"2020","unstructured":"Zhao X, Ding L, Lu Z, Huang X, Jing Y, Yang Y, et al. Diminished CD68(+) cancer-associated fibroblast subset induces regulatory T-cell (Treg) infiltration and predicts poor prognosis of oral squamous cell carcinoma patients. Am J Pathol. 2020;190(4):886\u201399.","journal-title":"Am J Pathol"},{"issue":"4","key":"1908_CR49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2326-6066.CIR-19-0507","volume":"8","author":"H Xiang","year":"2020","unstructured":"Xiang H, Ramil CP, Hai J, Zhang C, Wang H, Watkins AA, et al. Cancer-associated fibroblasts promote immunosuppression by inducing ROS-generating monocytic MDSCs in lung squamous cell carcinoma. Cancer Immunol Res. 2020;8(4):436\u201350.","journal-title":"Cancer Immunol Res"},{"key":"1908_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.7","author":"JT Cheng","year":"2016","unstructured":"Cheng JT, Deng YN, Yi HM, Wang GY, Fu BS, Chen WJ, et al. Hepatic carcinoma-associated fibroblasts induce ido-producing regulatory dendritic cells through il-6-mediated stat3 activation. Oncogenesis. 2016;5(2):e198.\u00a0https:\/\/doi.org\/10.1038\/oncsis.2016.7.","journal-title":"Oncogenesis"},{"issue":"8","key":"1908_CR51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"issue":"1","key":"1908_CR52","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","volume":"9","author":"MA Lakins","year":"2018","unstructured":"Lakins MA, Ghorani E, Munir H, Martins CP, Shields JD. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 (+) T cells to protect tumour cells. Nat Commun. 2018;9(1):948.","journal-title":"Nat Commun"},{"issue":"3","key":"1908_CR53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33(3):463-479.e10.","journal-title":"Cancer Cell"},{"key":"1908_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14134-w","author":"F Pelon","year":"2020","unstructured":"Pelon F, Bourachot B, Kieffer Y, Magagna I, Mermet-Meillon F, Bonnet I, et al. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nat Commun. 2020;11(1):404.\u00a0https:\/\/doi.org\/10.1038\/s41467-019-14134-w.","journal-title":"Nat Commun"},{"issue":"1","key":"1908_CR55","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/s41467-018-03348-z","volume":"9","author":"AM Givel","year":"2018","unstructured":"Givel AM, Kieffer Y, Scholer-Dahirel A, Sirven P, Cardon M, Pelon F, et al. Mir200-regulated CXCL12\u03b2 promotes fibroblast heterogeneity and immunosuppression in ovarian cancers. Nat Commun. 2018;9(1):1056.","journal-title":"Nat Commun"},{"issue":"4","key":"1908_CR56","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","volume":"172","author":"S Su","year":"2018","unstructured":"Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell. 2018;172(4):841-856.e16.","journal-title":"Cell"},{"issue":"1","key":"1908_CR57","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1038\/s41467-018-07582-3","volume":"9","author":"M Bartoschek","year":"2018","unstructured":"Bartoschek M, Oskolkov N, Bocci M, L\u00f6vrot J, Larsson C, Sommarin M, et al. Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing. Nat Commun. 2018;9(1):5150.","journal-title":"Nat Commun"},{"key":"1908_CR58","doi-asserted-by":"crossref","unstructured":"Bertoncello I. The lung cancer stem cell niche. 2021;85\u2013136.","DOI":"10.1016\/bs.asn.2020.10.002"},{"key":"1908_CR59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 2005;121:335\u201348.","journal-title":"Cell"},{"issue":"1","key":"1908_CR60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11684-016-0431-5","volume":"10","author":"A Qiao","year":"2016","unstructured":"Qiao A, Gu F, Guo X, Zhang X, Fu L. Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications. Front Med. 2016;10(1):33\u201340.","journal-title":"Front Med"},{"key":"1908_CR61","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ceb.2010.08.015","volume":"22","author":"M Egeblad","year":"2010","unstructured":"Egeblad M, Rasch MG, Weaver VM. Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol. 2010;22:697\u2013706.","journal-title":"Curr Opin Cell Biol"},{"key":"1908_CR62","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ncb1658","volume":"9","author":"C Gaggioli","year":"2007","unstructured":"Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol. 2007;9:1392\u2013400.","journal-title":"Nat Cell Biol"},{"key":"1908_CR63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-1875","author":"C Pe\u00f1a","year":"2013","unstructured":"Pe\u00f1a C, C\u00e9spedes MV, Lindh MB. Stc1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. Cancer Res. 2013;73(4):1287-1297.\u00a0https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1875.","journal-title":"Cancer Res"},{"key":"1908_CR64","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1111\/cas.15786","volume":"114","author":"S Sato","year":"2023","unstructured":"Sato S, Hiruma T, Koizumi M, Yoshihara M, Nakamura Y, Tadokoro H, et al. Bone marrow adipocytes induce cancer-associated fibroblasts and immune evasion, enhancing invasion and drug resistance. Cancer Sci. 2023;114:2674\u201388.","journal-title":"Cancer Sci"},{"key":"1908_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.10.015","author":"S Wen","year":"2019","unstructured":"Wen S, Hou Y, Fu L, Xi L, Yang D. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin \u03b23\u2013p38 MAPK signalling. Cancer Lett. 2019;442:320-332.\u00a0https:\/\/doi.org\/10.1016\/j.canlet.2018.10.015.","journal-title":"Cancer Lett"},{"key":"1908_CR66","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/bjc.2013.768","volume":"110","author":"Y Yu","year":"2014","unstructured":"Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ, Feng YM. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signalling. Br J Cancer. 2014;110:724\u201332.","journal-title":"Br J Cancer"},{"issue":"9","key":"1908_CR67","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jtho.2016.05.025","volume":"11","author":"Y Shintani","year":"2016","unstructured":"Shintani Y, Fujiwara A, Kimura T, Kawamura T, Funaki S, Minami M, et al. IL-6 secreted from cancer-associated fibroblasts mediates chemoresistance in NSCLC by increasing epithelial-mesenchymal transition signaling. J Thoracic Oncol. 2016;11(9):1482\u201392.","journal-title":"J Thoracic Oncol"},{"key":"1908_CR68","doi-asserted-by":"publisher","DOI":"10.3727\/096504017X14934840662335","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yao J, Li W, Zhang C. Micro-RNA-21 regulates cancer-associated fibroblast-mediated drug resistance in pancreatic cancer. Oncol Res Featur Preclin Clin Cancer Ther. 2018;26(6):827-835.\u00a0https:\/\/doi.org\/10.3727\/096504017X14934840662335.","journal-title":"Oncol Res Featur Preclin Clin Cancer Ther"},{"key":"1908_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061393","author":"CM Garvey","year":"2020","unstructured":"Garvey CM, Lau R, Sanchez A, Sun RX. Anti-EGFR therapy induces EGF secretion by cancer-associated fibroblasts to confer colorectal cancer chemoresistance. Cancers. 2020;12(6):1393.\u00a0https:\/\/doi.org\/10.3390\/cancers12061393.","journal-title":"Cancers"},{"key":"1908_CR70","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1084\/jem.20150576","volume":"212","author":"CK Pallangyo","year":"2015","unstructured":"Pallangyo CK, Ziegler PK, Greten FR. IKK\u03b2 acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis. J Exp Med. 2015;212:2253\u201366.","journal-title":"J Exp Med"},{"issue":"12","key":"1908_CR71","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1172\/JCI38988","volume":"119","author":"AM Santos","year":"2009","unstructured":"Santos AM, Jung J, Aziz N, Kissil JL, Pur\u00e9 E. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest. 2009;119(12):3613\u201325.","journal-title":"J Clin Invest"},{"issue":"6","key":"1908_CR72","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","volume":"25","author":"BC \u00d6zdemir","year":"2014","unstructured":"\u00d6zdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014;25(6):719\u201334.","journal-title":"Cancer Cell"},{"issue":"50","key":"1908_CR73","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, Jones JO, Kraman M, Wells RJB, Deonarine A, Chan DS, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A. 2013;110(50):20212\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1908_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3516","author":"VP Chauhan","year":"2013","unstructured":"Chauhan VP, Martin JD, Liu H, Lacorre DA, Jain SR, Kozin SV, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun. 2013;4:2516.\u00a0https:\/\/doi.org\/10.1038\/ncomms3516.","journal-title":"Nat Commun"},{"issue":"4","key":"1908_CR75","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2011.06.047","volume":"141","author":"FEM Froeling","year":"2011","unstructured":"Froeling FEM, Feig C, Chelala C, Dobson R, Mein CE, Tuveson DA, et al. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt\u03b2-catenin signaling to slow tumor progression. Gastroenterology. 2011;141(4):1486-1497.e14.","journal-title":"Gastroenterology"},{"issue":"3","key":"1908_CR76","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/0008-5472.CAN-16-0866","volume":"77","author":"L Miao","year":"2017","unstructured":"Miao L, Liu Q, Lin CM, Luo C, Wang Y, Liu L, et al. Targeting tumor-associated fibroblasts for therapeutic delivery in desmoplastic tumors. Cancer Res. 2017;77(3):719\u201331.","journal-title":"Cancer Res"},{"issue":"1","key":"1908_CR77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12935-021-01870-7","volume":"21","author":"Y Li","year":"2021","unstructured":"Li Y, Gu L. Establishment and characterization of HXWMF-1: the first mouse fibroblastic tumor cell line derived from leukemia-associated fibroblasts. Cancer Cell Int. 2021;21(1):177.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"1908_CR78","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41375-018-0373-9","volume":"33","author":"MW Lee","year":"2019","unstructured":"Lee MW, Ryu S, Kim DS, Lee JW, Sung KW, Koo HH, et al. Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges. Leukemia. 2019;33(3):597\u2013611.","journal-title":"Leukemia"},{"issue":"12","key":"1908_CR79","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1002\/jcp.26860","volume":"233","author":"M Soundararajan","year":"2018","unstructured":"Soundararajan M, Kannan S. Fibroblasts and mesenchymal stem cells: Two sides of the same coin? J Cell Physiol. 2018;233(12):9099\u2013109.","journal-title":"J Cell Physiol"},{"key":"1908_CR80","doi-asserted-by":"crossref","first-page":"110610","DOI":"10.1016\/j.biopha.2020.110610","volume":"130","author":"C Pan","year":"2020","unstructured":"Pan C, Liu P, Ma D, Zhang S, Ni M, Fang Q, et al. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia. Biomed Pharmacother. 2020;130:110610.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1908_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0405-0","volume":"35","author":"Y Zhai","year":"2016","unstructured":"Zhai Y, Zhang J, Wang H, Lu W, Liu S, Yu Y, et al. Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells. J Exp Clin Cancer Res. 2016;35(1):1\u201312.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"1908_CR82","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/leu.2013.254","volume":"28","author":"MA Frassanito","year":"2014","unstructured":"Frassanito MA, Rao L, Moschetta M, Ria R, Di Marzo L, De Luisi A, et al. Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: in vitro and in vivo studies. Leukemia. 2014;28(4):904\u201316.","journal-title":"Leukemia"},{"key":"1908_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060822","author":"L Schulze-Edinghausen","year":"2019","unstructured":"Schulze-Edinghausen L, D\u00fcrr C, \u00d6zt\u00fcrk S, Zucknick M, Benner A, Kalter V, et al. Dissecting the prognostic significance and functional role of progranulin in chronic lymphocytic leukemia. Cancers (Basel). 2019;11(6):822. \u00a0https:\/\/doi.org\/10.3390\/cancers11060822.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"1908_CR84","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2014-12-618025","volume":"126","author":"J Paggetti","year":"2015","unstructured":"Paggetti J, Haderk F, Seiffert M, Janji B, Distler U, Ammerlaan W, et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 2015;126(9):1106\u201317.","journal-title":"Blood"},{"issue":"5","key":"1908_CR85","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jb\/mvaa064","volume":"168","author":"Y Yang","year":"2020","unstructured":"Yang Y, Li JGY. Exosomes derived from chronic lymphocytic leukaemia cells transfer miR-146a to induce the transition of mesenchymal stromal cells into cancer-associated fibroblasts. J Biochem. 2020;168(5):491\u20138.","journal-title":"J Biochem"},{"issue":"Supplement 1","key":"1908_CR86","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood-2018-99-116409","volume":"132","author":"B Apollonio","year":"2018","unstructured":"Apollonio B, Jarvis P, Phillips B, Kuhnl A, Salisbury J, Zacharioudakis G, et al. Diffuse large B-cell lymphoma remodels the fibroblastic reticular network that acquires aberrant immunosuppressive capabilities; implications for the regulation of anti-tumor immunity in the immuno-oncology era. Blood. 2018;132(Supplement 1):675\u2013675.","journal-title":"Blood"},{"issue":"23","key":"1908_CR87","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/blood.V126.23.1474.1474","volume":"126","author":"B Apollonio","year":"2015","unstructured":"Apollonio B, Nicholas NS, Sutton LA, Salisbury J, Patten PE, Kassam S, et al. Diffuse large B-cell lymphoma (DLBCL) tumor cells reprogram lymphatic fibroblasts into cancer-associated fibroblasts (CAFs) that contribute to tumor microenvironment (TME)-driven immune privilege. Blood. 2015;126(23):1474\u20131474.","journal-title":"Blood"},{"issue":"10","key":"1908_CR88","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.4161\/cbt.29924","volume":"15","author":"F Zi","year":"2014","unstructured":"Zi F, He J, Li Y, Wu C, Wu W, Yang Y, et al. Fibroblast activation protein protects bortezomib- induced apoptosis in multiple myeloma cells through \u03b2 -catenin signaling pathway. Cancer Biol Ther. 2014;15(10):1413\u201322.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"1908_CR89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2012.12.003","volume":"23","author":"G Lutzny","year":"2013","unstructured":"Lutzny G, Kocher T, Schmidt-Supprian M, Rudelius M, Klein-Hitpass L, Finch AJ, et al. Protein kinase c-\u03b2-dependent activation of NF-\u03baB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo. Cancer Cell. 2013;23(1):77\u201392.","journal-title":"Cancer Cell"},{"issue":"3","key":"1908_CR90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jid.2020.06.034","volume":"141","author":"A Aronovich","year":"2021","unstructured":"Aronovich A, Moyal L, Gorovitz B, Amitay-Laish I, Naveh HP, Forer Y, et al. Cancer-associated fibroblasts in mycosis fungoides promote tumor cell migration and drug resistance through CXCL12\/CXCR4. J Invest Dermatol. 2021;141(3):619-627.e2.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"1908_CR91","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/or.2020.7874","volume":"45","author":"S Mei","year":"2021","unstructured":"Mei S, Zhang Y, Yu L, Chen G, Zi F. Expression and role of fibroblast activation protein \u03b1 in acute myeloid leukemia. Oncol Rep. 2021;45(2):641\u201351.","journal-title":"Oncol Rep"},{"key":"1908_CR92","doi-asserted-by":"crossref","first-page":"708513","DOI":"10.3389\/fcell.2021.708513","volume":"9","author":"C Pan","year":"2021","unstructured":"Pan C, Fang Q, Liu P, Ma D, Cao S, Zhang L, et al. Mesenchymal stem cells with cancer-associated fibroblast-like phenotype stimulate SDF-1\/CXCR4 axis to enhance the growth and invasion of B-cell acute lymphoblastic leukemia cells through cell-to-cell communication. Front Cell Dev Biol. 2021;9:708513.","journal-title":"Front Cell Dev Biol"},{"key":"1908_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041466","author":"M Mangolini","year":"2020","unstructured":"Mangolini M, Ringshausen I. Bone marrow stromal cells drive key hallmarks of B cell malignancies. Int J Mol Sci. 2020;21(4):1466. \u00a0https:\/\/doi.org\/10.3390\/ijms21041466.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1908_CR94","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/cas.13873","volume":"110","author":"A Sakamoto","year":"2019","unstructured":"Sakamoto A, Kunou S, Shimada K, Tsunoda M, Aoki T, Iriyama C, et al. Pyruvate secreted from patient-derived cancer-associated fibroblasts supports survival of primary lymphoma cells. Cancer Sci. 2019;110(1):269\u201378.","journal-title":"Cancer Sci"},{"issue":"8","key":"1908_CR95","doi-asserted-by":"crossref","first-page":"13085","DOI":"10.18632\/oncotarget.14393","volume":"8","author":"T Aoki","year":"2017","unstructured":"Aoki T, Shimada K, Sakamoto A, Sugimoto K, Morishita T, Kojima Y, et al. Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism. Oncotarget. 2017;8(8):13085\u201398.","journal-title":"Oncotarget"},{"key":"1908_CR96","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3389\/fimmu.2018.01358","volume":"9","author":"B D\u00f6rsam","year":"2018","unstructured":"D\u00f6rsam B, B\u00f6sl T, Reiners KS, Barnert S, Schubert R, Shatnyeva O, et al. Hodgkin lymphoma-derived extracellular vesicles change the secretome of fibroblasts toward a CAF phenotype. Front Immunol. 2018;9:1358.","journal-title":"Front Immunol"},{"key":"1908_CR97","first-page":"e4","volume":"127\u2013138","author":"MA Reid","year":"2019","unstructured":"Reid MA, Sanderson SM, Locasale JW. Cancer metabolism. abeloff\u2019s. Clin Oncol. 2019;127\u2013138:e4.","journal-title":"Clin Oncol"},{"issue":"23","key":"1908_CR98","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1038\/s41388-021-01829-y","volume":"40","author":"S Kunou","year":"2021","unstructured":"Kunou S, Shimada K, Takai M, Sakamoto A, Aoki T, Hikita T, et al. Exosomes secreted from cancer-a ssociated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma. Oncogene. 2021;40(23):3989\u20134003.","journal-title":"Oncogene"},{"issue":"1","key":"1908_CR99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08142-7","volume":"21","author":"SJ Mehdi","year":"2021","unstructured":"Mehdi SJ, Moerman-Herzog A, Wong HK. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma. BMC Cancer. 2021;21(1):1\u201312.","journal-title":"BMC Cancer"},{"issue":"3","key":"1908_CR100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jid.2020.08.006","volume":"141","author":"C Assaf","year":"2021","unstructured":"Assaf C. Cancer-associated fibroblasts play an important role in early-stage mycosis fungoides. J Invest Dermatol. 2021;141(3):479\u201380.","journal-title":"J Invest Dermatol"},{"key":"1908_CR101","first-page":"1","volume":"13","author":"EH Joo","year":"2022","unstructured":"Joo EH, Bae JH, Park J, Bang YJ, Han J, Gulati N, et al. Deconvolution of adult T-cell leukemia\/lymphoma with single-cell RNA-seq using frozen archived skin tissue reveals new subset of cancer-associated fibroblast. Front Immunol. 2022;13:1\u201313.","journal-title":"Front Immunol"},{"issue":"2","key":"1908_CR102","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/path.5187","volume":"247","author":"MA Frassanito","year":"2019","unstructured":"Frassanito MA, Desantis V, Di Marzo L, Craparotta I, Beltrame L, Marchini S, et al. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes. J Pathol. 2019;247(2):241\u201353.","journal-title":"J Pathol"},{"issue":"1","key":"1908_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3183-y","volume":"17","author":"S Ciavarella","year":"2017","unstructured":"Ciavarella S, Laurenzana A, De Summa S, Pilato B, Chill\u00e0 A, Lacalamita R, et al. u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression. BMC Cancer. 2017;17(1):1\u201311.","journal-title":"BMC Cancer"},{"issue":"7","key":"1908_CR104","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00277-018-3293-x","volume":"97","author":"V Desantis","year":"2018","unstructured":"Desantis V, Frassanito MA, Tamma R, Saltarella I, Di Marzo L, Lamanuzzi A, et al. Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma. Ann Hematol. 2018;97(7):1251\u20138.","journal-title":"Ann Hematol"},{"issue":"17","key":"1908_CR105","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.2019001398","volume":"134","author":"R Burt","year":"2019","unstructured":"Burt R, Dey A, Aref S, Aguiar M, Akarca A, Bailey K, et al. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress. Blood. 2019;134(17):1415\u201329.","journal-title":"Blood"},{"issue":"8","key":"1908_CR106","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1080\/10428194.2016.1263841","volume":"58","author":"AM Staiger","year":"2017","unstructured":"Staiger AM, Duppel J, Dengler MA, van der Kuip H, V\u00f6hringer MC, Aulitzky WE, et al. An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis. Leuk Lymphoma. 2017;58(8):1922\u201330.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1908_CR107","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/leu.2015.289","volume":"30","author":"MA Frassanito","year":"2016","unstructured":"Frassanito MA, Veirman KD, Desantis V, Marzo LD, Vergara D, Ruggieri S, et al. Halting pro-survival autophagy by TGF \u03b2 inhibition in bone marrow fi broblasts overcomes bortezomib resistance in multiple myeloma patients. Leukemia. 2016;30(3):640\u20138.","journal-title":"Leukemia"},{"issue":"26","key":"1908_CR108","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1182\/blood.2021012811","volume":"139","author":"R Sakemura","year":"2022","unstructured":"Sakemura R, Hefazi M, Siegler EL, Cox MJ, Larson DP, Hansen MJ, et al. Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma. Blood. 2022;139(26):3708\u201321.","journal-title":"Blood"},{"issue":"2","key":"1908_CR109","first-page":"1","volume":"13","author":"H Wang","year":"2021","unstructured":"Wang H, Liu H, Sun C, Liu C, Jiang T, Yin Y, et al. Nanoparticles dual targeting both myeloma cells and cancer-associated fibroblasts simultaneously to improve multiple myeloma treatment. Pharmaceutics. 2021;13(2):1\u201315.","journal-title":"Pharmaceutics"},{"key":"1908_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01185-6","author":"M Martello","year":"2024","unstructured":"Martello M, Solli V, Mazzocchetti G, Solimando AG, Bezzi D, Taurisano B, et al. High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis. Blood Cancer J. 2024;14(1):208.\u00a0https:\/\/doi.org\/10.1038\/s41408-024-01185-6.","journal-title":"Blood Cancer J"},{"issue":"1","key":"1908_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-36092-6","volume":"13","author":"S Miaomiao","year":"2023","unstructured":"Miaomiao S, Xiaoqian W, Yuwei S, Chao C, Chenbo Y, Yinghao L, et al. Cancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma. Sci Rep. 2023;13(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"5","key":"1908_CR112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hem3.70145","volume":"9","author":"SK Leivonen","year":"2025","unstructured":"Leivonen SK, Karihtala K, Pellinen T, Karjalainen-Lindsberg ML, Aoki T, Steidl C, et al. Characterization of cancer-associated fibroblasts and their spatial architecture reveals heterogeneity and survival associations in classic Hodgkin lymphoma. HemaSphere. 2025;9(5):1\u201313.","journal-title":"HemaSphere"},{"key":"1908_CR113","doi-asserted-by":"publisher","DOI":"10.1177\/03000605251331250","author":"H Cui","year":"2025","unstructured":"Cui H, Chen M, Zhao M, Li B. A novel cancer-associated fibroblast\u2013related gene signature for predicting diffuse large B cell lymphoma prognosis using weighted gene co-expression network analysis and machine learning. J Int Med Res. 2025;53(4):3000605251331250.\u00a0https:\/\/doi.org\/10.1177\/03000605251331250.","journal-title":"J Int Med Res"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01908-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01908-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01908-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:48:40Z","timestamp":1764917320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01908-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01908-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"367"}}